Substituted androst-4-ene diones

Details for Australian Patent Application No. 2011237592 (hide)

Owner The Research Foundation of State of New York Emory University Hauptman-Woodward Medical Research Institute

Inventors Davies, Huw; Ghosh, Debashis; Morton, Daniel

Agent Shelston IP

Pub. Number AU-A-2011237592

PCT Pub. Number WO2011/127232

Priority 61/322,062 08.04.10 US

Filing date 7 April 2011

Wipo publication date 13 October 2011

International Classifications

C07J 1/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

A61K 31/566 - having an oxo group in position 17, e.g. oestrone

A61P 5/00 Drugs for disorders of the endocrine system

A61P 35/00 Antineoplastic agents

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/127232 Priority application(s): WO2011/127232

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237598-Multi-well interference testing and insitu reservoir behavior characterization

2011237591-Patient eye level touch control